138 related articles for article (PubMed ID: 1694992)
1. Preparation of asialofetuin-labeled liposomes with encapsulated human interferon-gamma and their uptake by isolated rat hepatocytes.
Ishihara H; Hara T; Aramaki Y; Tsuchiya S; Hosoi K
Pharm Res; 1990 May; 7(5):542-6. PubMed ID: 1694992
[TBL] [Abstract][Full Text] [Related]
2. Specific uptake of asialofetuin-tacked liposomes encapsulating interferon-gamma by human hepatoma cells and its inhibitory effect on hepatitis B virus replication.
Ishihara H; Hayashi Y; Hara T; Aramaki Y; Tsuchiya S; Koike K
Biochem Biophys Res Commun; 1991 Jan; 174(2):839-45. PubMed ID: 1704230
[TBL] [Abstract][Full Text] [Related]
3. Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes.
Hara T; Kuwasawa H; Aramaki Y; Takada S; Koike K; Ishidate K; Kato H; Tsuchiya S
Biochim Biophys Acta; 1996 Jan; 1278(1):51-8. PubMed ID: 8611607
[TBL] [Abstract][Full Text] [Related]
4. Preparation and disposition of asialofetuin-labelled liposome.
Tsuchiya S; Aramaki Y; Hara T; Hosoi K; Okada A
Biopharm Drug Dispos; 1986; 7(6):549-58. PubMed ID: 2435334
[TBL] [Abstract][Full Text] [Related]
5. Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes.
Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
Gene; 1995 Jul; 159(2):167-74. PubMed ID: 7542617
[TBL] [Abstract][Full Text] [Related]
6. Specific incorporation of asialofetuin-labeled liposomes into hepatocytes through the action of galactose-binding protein.
Hara T; Aramaki Y; Tsuchiya S; Hosoi K; Okada A
Biopharm Drug Dispos; 1987; 8(4):327-39. PubMed ID: 2441770
[TBL] [Abstract][Full Text] [Related]
7. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.
Wu J; Liu P; Zhu JL; Maddukuri S; Zern MA
Hepatology; 1998 Mar; 27(3):772-8. PubMed ID: 9500706
[TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes.
Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
Gene Ther; 1995 Dec; 2(10):784-8. PubMed ID: 8750019
[TBL] [Abstract][Full Text] [Related]
9. Intracellular delivery of membrane-impermeable hydrophilic molecules to a hepatoblastoma cell line by asialoglycoprotein-labeled liposomes.
Yu HY; Lin JH
J Formos Med Assoc; 2000 Dec; 99(12):936-41. PubMed ID: 11155748
[TBL] [Abstract][Full Text] [Related]
10. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes.
Arangoa MA; Düzgüneş N; Tros de Ilarduya C
Gene Ther; 2003 Jan; 10(1):5-14. PubMed ID: 12525832
[TBL] [Abstract][Full Text] [Related]
11. Characterization, stability and in-vivo distribution of asialofetuin glycopeptide incorporating DSPC/CHOL liposomes prepared by mild cholate incubation.
Kallinteri P; Liao WY; Antimisiaris SG; Hwang KH
J Drug Target; 2001 Apr; 9(2):155-68. PubMed ID: 11697109
[TBL] [Abstract][Full Text] [Related]
12. Intracellular degradation of asialoglycoproteins in hepatocytes starts in a subgroup of lysosomes.
Berg T; Ford T; Kindberg G; Blomhoff R; Drevon C
Exp Cell Res; 1985 Feb; 156(2):570-4. PubMed ID: 2578406
[TBL] [Abstract][Full Text] [Related]
13. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
[TBL] [Abstract][Full Text] [Related]
14. Asialofetuin liposome-mediated human alpha1-antitrypsin gene transfer in vivo results in stationary long-term gene expression.
Dasí F; Benet M; Crespo J; Crespo A; Aliño SF
J Mol Med (Berl); 2001 May; 79(4):205-12. PubMed ID: 11409712
[TBL] [Abstract][Full Text] [Related]
15. Mouse interferon-gamma in liposomes: pharmacokinetics, organ-distribution, and activation of spleen and liver macrophages in vivo.
Hockertz S; Franke G; Kniep E; Lohmann-Matthes ML
J Interferon Res; 1989 Oct; 9(5):591-602. PubMed ID: 2507661
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of asialoglycoproteins in cultured rat hepatocytes: evidence for receptor mediated uptake and degradation which is not feed-back regulated.
Drevon CA; Tolleshaug H; Carlander B; Berg T
Int J Biochem; 1983; 15(6):827-33. PubMed ID: 6190689
[TBL] [Abstract][Full Text] [Related]
17. Targeting of lactosylceramide-containing liposomes to hepatocytes in vivo.
Spanjer HH; Scherphof GL
Biochim Biophys Acta; 1983 Sep; 734(1):40-7. PubMed ID: 6193809
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells.
Maitani Y; Kawano K; Yamada K; Nagai T; Takayama K
J Control Release; 2001 Aug; 75(3):381-9. PubMed ID: 11489324
[TBL] [Abstract][Full Text] [Related]
19. [Study on the hepatocytic cell targetability of liposomes].
Hou XP; Wang L; Wang XT; Li S
Yao Xue Xue Bao; 2003 Feb; 38(2):143-6. PubMed ID: 12778752
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic study of liposome-encapsulated human interferon-gamma after intravenous and intramuscular injection in mice.
Rutenfranz I; Bauer A; Kirchner H
J Interferon Res; 1990 Jun; 10(3):337-41. PubMed ID: 2117038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
